A scientific team at Barnsley Hospital and the University of Sheffield in the UK concluded that men with type 2 diabetes or the metabolic syndrome, or both, are prone to have low testosterone levels. If so, testosterone replacement therapy with a gel applied to the skin may improve their response to insulin and their sexual function, according to the results of a new clinical trial.
The study showed a statistically significant improvement in insulin sensitivity in testosterone-treated men at 6 and 12 months. Testosterone therapy also led to a significant improvement in the score on a standard assessment of erectile function after 6 and 12 months.
The study was presented at Endocrine Society’s annual meeting in San Francisco this week.
No User Responded In This Post
Leave Your Comments Here...